Can-Fite BioPharma Files Lawsuit AGainst Capital Point Alleging 'improper conduct in its attempt to exert control over the Company by, among things, unlawfully requesting that the Company convene a shareholders' meeting to replace its directors.'
Benzinga Newsdesk